7Price PA, Parthemore JG, Deftos LJ,et al. New biochemical marker for bone metabolism[J]. J Clin Invest, 1980,66 : 878.
8Kanis JA, Johnell O, Black DM, et al. Effect of raloxirene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of multiple outcomes of raloxifene evaluation trial[ J ]. Bone, 2003, 33 : 293 - 300.
9Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomized clinical trial. Multiple outcomes of raloxifene evaluation (MORE)[J]. JAMA, 1999, 282:637-645.
10Delmas PD, Ensrud KE, Adaehi JT, et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial[ J ]. J Clin Endoerinol & Metab, 2002, 87:3609-3617.
7Inan Anaforoglu,Asli Nar-Demirer,Neslihan Bascil-Tutuncu,Melek Eda Ertorer.Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes[J].Journal of Diabetes and Its Complications.2009(1)
8孙之镐.中西医结合骨伤科学[M].北京:中国中医药出版社,2006:489.
9Anaforoglu I, Nar-Denairer A, Bascil-Tutuncu N, et al.Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes[ J ] .J Diabetes Complications, 2009,23 ( 1 ): 12-17.
10Kaufman J J, Luo G, Siffert R S.Ultras0und simulation in bone[ J ]. IEEE Traus Uhrason Ferroelectr Freq Control,2008,55 (6): 1205-1218.
